nach oben

Erschienen in:

19.01.2016 | Review

Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation

verfasst von: Joanna E Fardell, Belinda Thewes, Jane Turner, Jemma Gilchrist, Louise Sharpe, Allan ‘Ben’ Smith, Afaf Girgis, Phyllis Butow

Erschienen in: Journal of Cancer Survivorship | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Fear of cancer recurrence (FCR) is prevalent among survivors. However, a comprehensive and universally accepted theoretical framework of FCR to guide intervention is lacking. This paper reviews theoretical frameworks previously used to explain FCR and describes the formulation of a novel theoretical framework for FCR.

Methods

A systematic review of the literature was undertaken to identify conceptual frameworks or theories applied to FCR. MEDLINE, PubMED, CINAHL, AMED, PsycINFO and Web of Science were searched. Identified conceptual frameworks were reviewed for strength of evidence supporting their validity.

Results

Of 558 papers initially identified, 16 made reference to six different conceptual frameworks relating to FCR. The most comprehensive and evidence-based theoretical approach is the Common Sense Model (CSM). Other approaches have limited evidence supporting their application to FCR. Two theoretical approaches developed in the context of emotional disorders that appear to be highly relevant to FCR: the Self-Regulatory Executive Function (S-REF) model and Relational Frame Theory were combined with the CSM to produce a novel cognitive processing account of FCR.

Conclusions

Few conceptual frameworks have been used consistently to guide FCR research, and not all frameworks are empirically well supported, suggesting that further discussion regarding the conceptualisation of FCR is needed. The novel theoretical framework for FCR presented highlights the multidimensional nature of FCR and the importance of cognitive processing and metacognitions in the development and maintenance of FCR.

Implications for Cancer Survivors

The novel theoretical formulation of FCR outlined here provides a much-needed comprehensive framework to further investigate and address FCR in cancer survivors.

Cella DF, Mahon SM, Donovan MI. Cancer recurrence as a traumatic event. Behav Med. 1990;16:15–22.CrossRefPubMed

Halldórsdóttir S, Hamrin E. Experiencing existential changes: the lived experience of having cancer. Cancer Nurs. 1996;19:29–36.CrossRefPubMed

Lagerdahl ASK, Moynihan M, Stollery B. An exploration of the existential experiences of patients following curative treatment for cancer: reflections from a UK sample. J Psychosoc Oncol. 2014;32(5):555–75.CrossRefPubMed

Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17:241–51.CrossRefPubMed

Kim Y, Carver CS, Spillers RL, et al. Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2012;21:517–25.CrossRef

Mellon S, Kershaw TS, Northouse LL, Freeman-Gibb L. A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psycho-Oncology. 2007;16:214–23.CrossRefPubMed

Simard S, Savard J. Screening and psychiatric comorbidity of clinical fear of cancer recurrence. 4th Canadian breast cancer research alliance reasons for hope scientific conference. Vancouver, Canada. 2008.

Thewes B, Butow P, Bell ML, et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer. 2012;20:2651–9.CrossRefPubMed

Hodges L, Humphris G. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psycho-Oncology. 2009;18:841–8.CrossRefPubMed

10.

Hart S, Latini D, Cowan J, et al. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008;16:161–9.CrossRefPubMed

11.

Lebel S, Tomei C, Feldstain A, et al. Does fear of cancer recurrence predict cancer survivors’ health care use? Support Care Cancer. 2013;21:901–6.CrossRefPubMed

12.

Llewellyn C, Weinman J, McGurk M, Humphris GM. Can we predict which head and neck cancer survivors develop fears of cancer recurrence? J Psychosom Res. 2008;65:525–32.CrossRefPubMed

13.

Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 2009;18:1273–80.CrossRef

14.

Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (>5 years) cancer survivors—a systematic review of quantitative studies. Psycho-Oncology. 2013;22:1–11.CrossRefPubMed

15.

Hodgkinson K. What is the psychosocial impact of cancer? In: Hodgkinson K, Gilchrist J, editors. Psychosocial care of cancer patients: a health professionals guide to what to say and do. Melbourne: Ausmed Publications; 2008.

16.

Armes J, Crowe M, Colbourne L, et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27:6172–9.CrossRefPubMed

17.

van den Beuken-van Everdingen MHJ, Peters ML, de Rijke JM, et al. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psycho-Oncology. 2008;17:1137–45.CrossRef

18.

Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho-Oncology. 2013;22:978–86.CrossRefPubMed

19.

Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Survivorship. 2013;7:300–22.CrossRef

20.

Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho-Oncology. 1997;6:95–105.CrossRefPubMed

21.

Witte K. Putting the fear back into fear appeals: the extended parallel process model. Commun Monogr. 1992;59:329–49.CrossRef

22.

McGinty HL, Goldenberg JL, Jacobsen PB. Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors. Psycho-Oncology. 2012;21:203–10.CrossRefPubMed

23.

Rippetoe PA, Rogers RW. Effects of components of protection-motivation theory on adaptive and maladaptive coping with a health threat. J Pers Soc Psychol. 1987;52:596–604.CrossRefPubMed

24.

Corter AL, Findlay M, Broom R, et al. Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer. Br J Health Psychol. 2013;18:168–81.CrossRefPubMed

25.

Park CL, Cho D, Blank TO, Wortmann JH. Cognitive and emotional aspects of fear of recurrence: predictors and relations with adjustment in young to middle-aged cancer survivors. Psycho-Oncology. 2013;22:1630–8.CrossRefPubMed

26.

Phillips KM, McGinty HL, Gonzalez BD, et al. Factors associated with breast cancer worry 3 years after completion of adjuvant treatment. Psycho-Oncology. 2013;22:936–9.CrossRefPubMed

27.

Easterling DV, Leventhal H. Contributions of concrete cognition to emotion: neutral symptoms as elicitors of worry about cancer. J Appl Psychol. 1989;74:787–96.CrossRefPubMed

28.

Hilton BA. The relationship of uncertainty, control, commitment, and threat of recurrence to coping strategies used by women diagnosed with breast cancer. J Behav Med. 1989;12:39–54.CrossRefPubMed

29.

Liu Y, Pérez M, Schootman M, et al. Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2011;130:165–73.CrossRefPubMedPubMedCentral

30.

Mishel MH. Uncertainty in chronic illness. Annu Rev Nurs Res. 1999;17:269–94.PubMed

31.

Lebel S, Maheu C, Lefebvre M, et al. Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Survivorship. 2014;8:485–96.CrossRef

32.

Mishel MH, Germino BB, Gil KM, et al. Benefits from an uncertainty management intervention for African-American and Caucasian older long-term breast cancer survivors. Psycho-Oncology. 2005;14:962–78.CrossRefPubMed

33.

Mast ME. Survivors of breast cancer: illness uncertainty, positive reappraisal, and emotional distress. Oncol Nurs Forum. 1998;25:555–62.PubMed

34.

Eisenberg SA, Kurita K, Taylor-Ford M, et al. Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors. Psycho-Oncology. 2015;24:228–35.CrossRefPubMed

35.

Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16:143–63.CrossRef

36.

Sharpe L, Curran L. Understanding the process of adjustment to illness. Soc Sci Med. 2006;62:1153–66.CrossRefPubMed

37.

Rabin C, Leventhal H, Goodin S. Conceptualization of disease timeline predicts posttreatment distress in breast cancer patients. Health Psychol. 2004;23:407–12.CrossRefPubMed

38.

Koch L, Bertram H, Eberle A, et al. Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship—a multi-regional population-based study. Psycho-Oncology. 2014;23:547–54.CrossRefPubMed

39.

Lipkus IM, Klein WMP, Skinner CS, Rimer BK. Breast cancer risk perceptions and breast cancer worry: what predicts what? J Risk Res. 2005;8:439–52.CrossRef

40.

Humphries G, Rogers S. AFTER and beyond: cancer recurrence fears and test of an intervention in oropharyngeal patients. Soc Sci Dent. 2012;2:29–38.

41.

Humphris GM, Ozackinci G. The AFTER intervention: a structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. Br J Health Psychol. 2008;13:223–30.CrossRefPubMed

42.

Wells A, Matthews G. Modelling cognition in emotional disorder: the S-REF model. Behav Res Ther. 1996;34:881–8.CrossRefPubMed

43.

Cavanagh M, Franklin J. Attention training and hypochondriasis: preliminary results of a controlled treatment trial. World congress of cognitive and behavioral therapy. Vancouver, Canada 2000.

44.

Baker P, Beesley H, Dinwoodie R, et al. ‘You’re putting thoughts into my head’: a qualitative study of the readiness of patients with breast, lung or prostate cancer to address emotional needs through the first 18 months after diagnosis. Psycho-Oncology. 2013;22:1402–10.CrossRefPubMed

45.

Macleod C, Hagan R. Individual differences in the selective processing of threatening information, and emotional responses to a stressful life event. Behav Res Ther. 1992;30:151–61.CrossRefPubMed

46.

Taylor L, Espie C, White C. Attentional bias in people with acute versus persistent insomnia secondary to cancer. Behav Sleep Med. 2003;1:200–12.CrossRefPubMed

47.

Chan MW, Ho SM, Tedeschi RG, Leung CW. The valence of attentional bias and cancer-related rumination in posttraumatic stress and posttraumatic growth among women with breast cancer. Psycho-Oncology. 2011;20:544–52.CrossRefPubMed

48.

Cook S, Salmon P, Dunn G et al. A prospective study of the association of metacognitive beliefs and processes with persistent emotional distress after diagnosis of cancer. Cogn Ther Res. 2014: 1–10.

49.

Cook SA, Salmon P, Dunn G et al. The association of metacognitive beliefs with emotional distress after diagnosis of cancer. Health Psychol. 2014: No Pagination Specified.

50.

Stanton AL, Danoff-burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psycho-Oncology. 2002;11:93–102.CrossRefPubMed

51.

Deimling GT, Bowman KF, Sterns S, et al. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psycho-Oncology. 2006;15:306–20.CrossRefPubMed

52.

Wells A. Detached mindfulness in cognitive therapy: a metacognitive analysis and ten techniques. J Ration Emot Cogn Behav Ther. 2005;23:337–55.CrossRef

53.

Lengacher C, Jonhson-Mallard V, Post-White J, et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology. 2009;18:1261–72.CrossRefPubMed

54.

Lengacher CA, Johnson-Mallard V, Barta M, et al. Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs. 2011;29:107–17.CrossRefPubMed

55.

Lengacher CA, Shelton MM, Reich RR, et al. Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med. 2014;37:185–95.CrossRefPubMed

56.

Hayes SC, Luoma JB, Bond FW, et al. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44:1–25.CrossRefPubMed

57.

Hayes S, Strohsahl K, Wilson K. Acceptance and commitment therapy; an experiential approach to behaviour change. New York: Guildford Press; 2003.

58.

Fletcher L, Hayes S. Relational frame theory, acceptance and commitment therapy, and a functional analytic definition of mindfulness. J Ration Emot Cogn Behav Ther. 2005;23:315–36.CrossRef

59.

Thewes B, Brebach R, Dzidowska M, et al. Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals. Psycho-Oncology. 2014;23:390–6.CrossRefPubMed

60.

Feros DL, Lane L, Ciarrochi J, Blackledge JT. Acceptance and commitment therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncology. 2013;22:459–64.PubMed

61.

Rost AD, Wilson K, Buchanan E, et al. Improving psychological adjustment among late-stage ovarian cancer patients: examining the role of avoidance in treatment. Cogn Behav Pract. 2012;19:508–17.CrossRef

62.

Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med. 1997;19:362–9.CrossRefPubMed

63.

Mishel MH. Uncertainty in illness. Image J Nurs Sch. 1988;20:225–32.CrossRefPubMed

64.

Butow P, Bell M, Smith A, et al. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer. 2013;13:201.CrossRefPubMedPubMedCentral

65.

Butow P, Kelly S, Thewes B, et al. Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence. Psycho-Oncology. 2015;24:416–23.CrossRefPubMed

66.

Thewes B, Bell ML, Butow P. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors. Psycho-Oncology. 2013;22:2059–63.CrossRefPubMed

67.

Persoskie A, Ferrer RA, Klein WM. Association of cancer worry and perceived risk with doctor avoidance: an analysis of information avoidance in a nationally representative us sample. J Behav Med. 2014;37:977–87.CrossRefPubMed

68.

Sharpe L, Thewes B, Butow P. Attentional biases in cancer survivors: directions for future research. Psycho-Oncology. 2015;24:496.CrossRefPubMed

69.

Lichtenthal WG, Tuman M, Beard C, et al. Development of attention and interpretation modification for fear of breast cancer recurrence (AIM-FBCR): preliminary findings. Psycho-Oncology. 2013;22:72–3.

70.

Smith AB, Thewes B, Turner J et al. Pilot of a theoretically grounded psychologist-delivered intervention for fear of cancer recurrence (Conquer Fear). Psycho-Oncology 2015: n/a-n/a.

Titel: Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation
verfasst von: Joanna E Fardell
Belinda Thewes
Jane Turner
Jemma Gilchrist
Louise Sharpe
Allan ‘Ben’ Smith
Afaf Girgis
Phyllis Butow
Publikationsdatum: 19.01.2016
Verlag: Springer US
Erschienen in: Journal of Cancer Survivorship / Ausgabe 4/2016
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-015-0512-5

Neu im Fachgebiet Onkologie

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Springer Medizin

Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Neu im Fachgebiet Onkologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Das Ende der vollständigen axillären Lymphknotendissektion

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Psychological impact of lymphoma on adolescents and young adults: not a matter of black or white

Distinct health behavior and psychosocial profiles of young adult survivors of childhood cancers: a mixed methods study

Prevalence and factors related to smoking and smoking cessation 6 months following a cancer diagnosis: a population-based study

Differences in limb volume trajectories after breast cancer treatment

The unmet emotional, care/support, and informational needs of adult survivors of pediatric malignancies

Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study

Neu im Fachgebiet Onkologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Das Ende der vollständigen axillären Lymphknotendissektion

Update Onkologie